95586 ⎘
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
ANTIBIOTIC CONJUGATES
#2Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-ACA)
#3Derivatized 3-styryl-cephalosporins
#4Broad spectrum beta-lactamase inhibitors
#5Broad spectrum beta-lactamase inhibitors
#6Broad spectrum beta-lactamase inhibitors
#7Optically-Detectable Enzyme Substrates and Their Method of Use
#8Crystal form of Cefathiamidine compound and preparation method therefor
#9Broad spectrum beta-lactamase inhibitors
#10Optically-Detectable Enzyme Substrates and Their Method of Use
#11Derivatized 3-styryl-cephalosporins
#12CEPHALOSPORIN COMPOUND
#13Broad spectrum beta-lactamase inhibitors
#14Antibacterial compounds
#15Cephem compound having pyridinium group
#16Cephem compound having catechol or pseudo-catechol structure
#17Cephalosporin derivatives and pharmaceutical compositions thereof
#18Cephalosporin derivatives and pharmaceutical compositions thereof
#19USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS
#20Optically-detectable enzyme substrates and their method of use
#21Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Compositions
#22Process for preparing cefsulodin sodium
#23Broad spectrum beta-lactamase inhibitors
#24OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE
#25Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions
#26Process for the manufacture of cefpodoxime proxetil
#27Optically-detectable enzyme substrates and their method of use
#28Solid forms of ceftolozane